MARKET

BNTC

BNTC

Benitec Biopharm
NASDAQ
8.43
-0.20
-2.32%
Opening 13:51 10/14 EDT
OPEN
8.52
PREV CLOSE
8.63
HIGH
9.07
LOW
8.29
VOLUME
73.32K
TURNOVER
--
52 WEEK HIGH
16.76
52 WEEK LOW
8.29
MARKET CAP
294.06M
P/E (TTM)
-8.6170
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at BNTC last week (1005-1009)?
Weekly Report · 2d ago
BB-301 Momentum, Favorable FDA Feedback Support Buy Rating with Unchanged $32 Price Target
TipRanks · 10/06 11:05
FDA Clarity on BB-301 Phase 3 Supports Buy Rating on BNTC; $17 Price Target Reiterated
TipRanks · 10/05 18:25
Benitec Biopharma says BB-301 pivotal still on track for mid-2027
TipRanks · 10/05 13:10
Benitec advances BB-301 gene therapy after FDA feedback
TipRanks · 10/05 12:28
Weekly Report: what happened at BNTC last week (0928-1002)?
Weekly Report · 10/05 09:58
Analysts Are Bullish on Top Healthcare Stocks: RegenXBio (RGNX), Benitec Biopharma (BNTC)
TipRanks · 09/28 10:30
Weekly Report: what happened at BNTC last week (0921-0925)?
Weekly Report · 09/28 09:54
More
About BNTC
Benitec Biopharma Inc is a clinical-stage biotechnology company. The Company is focused on the advancement of novel genetic medicines. Its proprietary Silence and Replace deoxyribonucleic acid (DNA) -directed ribonucleic acid (RNA) interference platform combines RNA interference, or RNAi, with gene therapy to create medicines that simultaneously facilitate sustained silencing of disease-causing genes and concomitant delivery of wildtype replacement genes following a single administration of the therapeutic construct. The Company is developing Silence and Replace-based therapeutics (BB-301) for chronic and life-threatening human conditions including Oculopharyngeal Muscular Dystrophy (OPMD). BB-301 is an adeno-associated viral vector (AAV)-based gene therapy designed to silence the expression of disease-causing genes (to slow, or halt, the underlying mechanism of disease progression) and to simultaneously replace the mutant genes with normal, wildtype genes.

Webull offers Benitec Biopharma Inc stock information, including NASDAQ: BNTC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BNTC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BNTC stock methods without spending real money on the virtual paper trading platform.